Morphologic Switch From Psoriasiform to Eczematous Dermatitis After Anti-IL-17 Therapy
- 1 September 2019
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA Dermatology
- Vol. 155 (9) , 1082-1084
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- IL-17 Receptor A Maintains and Protects the Skin Barrier To Prevent Allergic Skin InflammationThe Journal of Immunology, 2017
- Atopic dermatitis exacerbated with ustekinumab in a psoriatic patient with childhood history of atopyAllergology International, 2015
- Mutual Antagonism of T Cells Causing Psoriasis and Atopic EczemaNew England Journal of Medicine, 2011
- Predictive Factors of Eczema-Like Eruptions among Patients without Cutaneous Psoriasis Receiving Infliximab: A Cohort Study of 92 PatientsDermatology, 2009
- Differential Roles of Interleukin-17A and -17F in Host Defense against Mucoepithelial Bacterial Infection and Allergic ResponsesImmunity, 2009